CNBC Investing Club Portfolio Rides Market Rally Top and Bottom Performers Emerge in SixWeek Surge Tech Media Telecom Roundup WSJ Market Talks Highlight DeepSeek and SoFi UK Labours Capital Gains Tax Plan Aligning Rates with Income Tax Could Reshape Investment Landscape Taiwan Chip Stocks Rise on Nvidias 150 Billion Spending Commitment Chinese AI Chip Makers Decline SpaceX Scrubs Starship Test Flight Sets Friday Retry for 12th Launch Tech Rally Propels SP 500 to New Record on May 26 2026 ALEC Q1 2026 Earnings NarrowerThanExpected Loss Surprises No Revenue Yet ESLA Q1 2026 Earnings EPS Misses Estimates by Wide Margin as ClinicalStage Biotech Continues RD Spending CELZ Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Advances Ameresco Inc AMRC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter BBDC Q1 2026 Earnings EPS Misses Estimates Amidst Stable Asset Performance HAYW Q1 2026 Earnings EPS Surprises to the Upside Amidst Quiet Revenue Picture ChargePoint Holdings Inc CHPT Gains Ground as Investor Sentiment Improves Core AI Holdings CHAI Slides 6 on Heavy Volume Key Support in Focus Drugs Made In America Acquisition II Corp Unit DMIIU Holds Steady Near Trust Value Amid Low Volatility SC II Acquisition Corp SCII Holds Steady at 1001 Amid Minimal Movement FTAIM Preferred Shares Hold Steady Near Support Yield Focus Remains Vanguard VCIT UltraLow Cost Bond ETF Attracts 3 Annual Fee Per 10K Uranium Royalty Corp UROY Q1 2026 Earnings EPS Turns Positive Topping Estimates by 199 Stock Slips 3 Credit Suisse Asset Management Income Fund Inc CIK Holds Steady at 252 Amid Narrow Trading Range WORX Q3 2025 Earnings Narrowed Loss and Rallying Stock Signal Investor Confidence InspireMD Inc NSPR Q1 2026 Earnings Narrower Loss Than Expected But Shares Slide Corvus Pharmaceuticals CRVS Q1 2026 Earnings RD Pipeline Progress Amid Slight EPS Miss CWAN Q1 2026 Earnings Slight EPS Miss Amid Steady Operations HLIT Q1 2026 Earnings Strong EPS Surprise Drives Stock Rally Willdan Group Q1 2026 Earnings EPS Beat Drives 32 Stock Gain Reviva Pharmaceuticals RVPH Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline Amid PreRevenue Stage